1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LAURUS LABS LTD.
Laurus Labs Ltd.
NSE: LAURUSLABS | BSE: 540222
Strong Performer, Getting Expensive
Download real time
Iran War Impact
Ask MarketMind AI
1108.75 -14.80 (-1.32%)
Near 52W High of ₹1144.85
1.0M
NSE+BSE Volume

NSE 28 Apr, 2026 12:30 PM (IST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Laurus Labs is on 30 Apr 2026 for the purpose of Audited Results & Interim Dividend See details

Laurus Labs quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents